Drug News
-
Scinai’s Aerosolized NanoAbs: Promising COVID-19 Prophylactic and Therapeutic, Study Finds
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products, has announced the publication…
Read More » -
Federal Judge Allows Lawsuit Over Ozempic Side Effects to Proceed
In a recent development, a federal judge in Louisiana has ruled against Novo Nordisk’s attempt to dismiss one of the…
Read More » -
Disappointment As Study Reveals Weight Regain in Patients After Discontinuation of Eli Lilly’s Zepbound
In a significant development, the full results of a study published in the journal JAMA on Monday have unveiled that…
Read More » -
Myanmar Emerges as World’s Largest Opium Source Amid Afghan Decline, UN Reports
In a startling revelation, Myanmar has now claimed the dubious distinction of being the world’s largest source of opium, surpassing…
Read More » -
Shuttle Pharma Submits Ropidoxuridine IND for Glioblastoma Treatment to FDA
Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”) has announced a significant stride in its mission to address glioblastoma, a…
Read More » -
Global H1N1 Vaccines Market Thrives: Intramuscular Segment and Hospital Pharmacies at the Forefront
A recent report by Research and Markets forecasts significant growth in the Global H1N1 Vaccines Market until 2028. This comprehensive…
Read More » -
Novartis Reports Positive 48-Week Results for Fabhalta in PNH Trial
Novartis Pharmaceuticals Corporation has released new 48-week results from the Phase III APPLY-PNH trial, showcasing sustained efficacy and long-term safety…
Read More » -
Hoba Therapeutics Raises EUR 23 Million in Series A Financing for Innovative Neuropathic Pain Treatment
Danish biotech company, Hoba Therapeutics, has successfully secured EUR 23 million (USD 25 million) in a Series A financing first…
Read More » -
Medtronic and Cosmo Pharmaceuticals Propel Healthcare Forward with AI-Driven Care Collaboration
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, has announced a definitive agreement to expand its partnership with…
Read More » -
FDA Approves Revolutionary Gene Therapies, Offering Lifelong Relief for Sickle Cell Disease
In a groundbreaking move, the U.S. Food and Drug Administration (FDA) granted approval on Friday to two gene therapies for…
Read More »